Side-by-side comparison of AI visibility scores, market position, and capabilities
Bethesda MD global hotel franchisor (NASDAQ: MAR) ~$24.2B FY2024 revenue; 9,100+ hotels, Bonvoy 230M members, asset-light 60%+ EBITDA margins, Ritz-Carlton/Sheraton/Westin competing with Hilton and Hyatt.
Marriott International, Inc. is a Bethesda, Maryland-based global hospitality company — publicly traded on the NASDAQ (NASDAQ: MAR) as an S&P 500 Consumer Discretionary component — managing and franchising 30+ hotel and lodging brands across all price segments (luxury: Ritz-Carlton, St. Regis, EDITION, W Hotels; premium: Marriott, Sheraton, Westin, Renaissance, Le Méridien; select service: Courtyard, Fairfield, SpringHill Suites, Moxy; extended stay: Residence Inn, Element; timeshare: Marriott Vacations Worldwide) through approximately 377,000 associates at 9,100+ properties with 1.7 million rooms in 141 countries. In fiscal year 2024, Marriott reported revenues of approximately $24.2 billion and adjusted EBITDA of $5.1 billion (+9% year-over-year), driven by RevPAR (Revenue Per Available Room) growth in all global regions as leisure and business travel demand normalized post-COVID and international inbound travel to the United States reached recovery levels. CEO Anthony Capuano continues the asset-light franchise and management model that Marriott executed through the transformational 2016 acquisition of Starwood Hotels & Resorts Worldwide ($13.6 billion — the largest hotel acquisition in history, adding Sheraton, Westin, W, St. Regis, and Luxury Collection) — creating the world's largest hotel company by room count and establishing the Marriott Bonvoy loyalty program (230+ million enrolled members, the largest hotel loyalty program globally) as the central customer retention and engagement platform. Marriott's asset-light model (owning essentially no hotels — instead managing and franchising third-party owned properties) generates fee-based revenue (franchise fees, management base and incentive fees, Bonvoy licensing fees to franchisees) at 60%+ EBITDA margins with minimal capital expenditure requirements, creating one of the highest-margin hospitality business models possible.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.